Spots Global Cancer Trial Database for recurrent solid tumors
Every month we try and update this database with for recurrent solid tumors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| ONO-4538 Phase I Study in Patients With Solid Tumor | NCT02261285 | Advanced Solid ... Recurrent Solid... | ONO-4538 | 20 Years - | Ono Pharmaceutical Co. Ltd | |
| Study of E7389 in Patients With Advanced Solid Tumors | NCT00069264 | Advanced Solid ... | E7389 | 18 Years - | Eisai Inc. | |
| Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy | NCT00222443 | Lymphomas Tumors | Irinotecan | 1 Year - 21 Years | University of Oklahoma | |
| Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors | NCT00024661 | Neoplasms | LErafAON | 18 Years - | INSYS Therapeutics Inc | |
| Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer | NCT03096340 | Cancer Neoplasms Tumors Refractory Soli... Recurrent Solid... | IT-141 | 18 Years - | Intezyne Technologies, Inc. | |
| ONO-4538 Phase I Study in Patients With Solid Tumor | NCT02261298 | Advanced Solid ... Recurrent Solid... | ONO-4538 | 20 Years - | Ono Pharmaceutical Co. Ltd | |
| Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid Tumors | NCT00966498 | High Risk Solid... Recurrent Solid... | Peripheral Bloo... | - 35 Years | Emory University | |
| A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors | NCT06031441 | Locally Advance... Recurrent Solid... Metastatic Soli... | RO7566802 Atezolizumab | 18 Years - | Genentech, Inc. | |
| Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors | NCT06234098 | Solid Tumor | AT-1965 Liposom... | 18 Years - | Alyssum Therapeutics | |
| Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy | NCT00222443 | Lymphomas Tumors | Irinotecan | 1 Year - 21 Years | University of Oklahoma | |
| Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer | NCT03096340 | Cancer Neoplasms Tumors Refractory Soli... Recurrent Solid... | IT-141 | 18 Years - | Intezyne Technologies, Inc. | |
| TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101) | NCT03247309 | Solid Tumor Cancer Recurrent Solid... Refractory Soli... | IMA201 Product IMADetect® | 18 Years - | Immatics US, Inc. | |
| Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer | NCT03096340 | Cancer Neoplasms Tumors Refractory Soli... Recurrent Solid... | IT-141 | 18 Years - | Intezyne Technologies, Inc. | |
| ZEN003694 Combined With Niraparib in Patients With Metastatic or Recurrent Solid Tumors | NCT06161493 | Ovarian Cancer Recurrent Solid... | ZEN003694 Niraparib | 18 Years - | University of Pittsburgh | |
| Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors | NCT06234098 | Solid Tumor | AT-1965 Liposom... | 18 Years - | Alyssum Therapeutics |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
